Soluble interferon-gamma receptor fragment
US5578707A · kind A · utility
19Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 1993 |
| Grant date | Nov 26, 1996 |
| Priority date | — |
| Expiry date | Feb 12, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/834
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Soluble human IFN-gamma receptor extracellular fragment and salts, functional derivatives, precursors and active fractions thereof are provided in substantially purified form. They are useful as pharmaceutically active substances for protecting against the deleterious effects of IFN-gamma, e.g. in autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.